Literature DB >> 25003671

Role of gut microbiota: obesity and NAFLD.

Venkatanarayana Gangarapu1, Kemal Yıldız, Ali Tüzün Ince, Birol Baysal.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease in developed countries. Obesity is the most important risk factor for metabolic syndrome and NAFLD. Accumulated evidence has revealed that gut microbial compositional changes may be associated with more energy harvesting from the diet, which promotes increased fatty acid uptake from adipose tissue and shifts lipid metabolism from oxidation to de novo production. Furthermore, changes in intestinal barrier function contribute to metabolic endotoxemia in the form of low-grade microbial inflammation. Persistent inflammation exacerbates NAFLD progression. In this review, we discuss the role of gut microbiota in obesity and NAFLD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25003671     DOI: 10.5152/tjg.2014.7886

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  20 in total

Review 1.  Human microbiome: From the bathroom to the bedside.

Authors:  Stephen Malnick; Ehud Melzer
Journal:  World J Gastrointest Pathophysiol       Date:  2015-08-15

Review 2.  Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective.

Authors:  Jun-Ling Han; Hui-Ling Lin
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

Review 3.  Innate immune signaling and gut-liver interactions in non-alcoholic fatty liver disease.

Authors:  Veerle Bieghs; Christian Trautwein
Journal:  Hepatobiliary Surg Nutr       Date:  2014-12       Impact factor: 7.293

Review 4.  Gut Microbiome and Obesity: A Plausible Explanation for Obesity.

Authors:  Claudia Sanmiguel; Arpana Gupta; Emeran A Mayer
Journal:  Curr Obes Rep       Date:  2015-06

5.  In Vitro Hepatoprotective and Human Gut Microbiota Modulation of Polysaccharide-Peptides in Pleurotus citrinopileatus.

Authors:  Yihua Huang; Yi Gao; Xionge Pi; Shuang Zhao; Wei Liu
Journal:  Front Cell Infect Microbiol       Date:  2022-05-20       Impact factor: 6.073

6.  A microbiological explanation for the obesity pandemic?

Authors:  Louis Valiquette; Stéphanie Sirard; Kevin Laupland
Journal:  Can J Infect Dis Med Microbiol       Date:  2014 Nov-Dec       Impact factor: 2.471

7.  PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes.

Authors:  Rosellina Margherita Mancina; Rocco Spagnuolo; Marta Milano; Simona Brogneri; Attilio Morrone; Cristina Cosco; Veronica Lazzaro; Cristina Russo; Yvelise Ferro; Piero Pingitore; Arturo Pujia; Tiziana Montalcini; Patrizia Doldo; Pietro Garieri; Luca Piodi; Flavio Caprioli; Luca Valenti; Stefano Romeo
Journal:  Inflamm Bowel Dis       Date:  2016-01       Impact factor: 5.325

Review 8.  Nonalcoholic Lipid Accumulation and Hepatocyte Malignant Transformation.

Authors:  Juanjuan Gu; Min Yao; Dengbing Yao; Li Wang; Xuli Yang; Dengfu Yao
Journal:  J Clin Transl Hepatol       Date:  2016-06-15

9.  The Placental Microbiome Varies in Association with Low Birth Weight in Full-Term Neonates.

Authors:  Jia Zheng; Xinhua Xiao; Qian Zhang; Lili Mao; Miao Yu; Jianping Xu
Journal:  Nutrients       Date:  2015-08-17       Impact factor: 5.717

10.  The programming effects of nutrition-induced catch-up growth on gut microbiota and metabolic diseases in adult mice.

Authors:  Jia Zheng; Xinhua Xiao; Qian Zhang; Miao Yu; Jianping Xu; Cuijuan Qi; Tong Wang
Journal:  Microbiologyopen       Date:  2016-01-08       Impact factor: 3.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.